Author: Fiona Craig

Blencowe Resources Plc (LSE:BRES) has reported further encouraging drill results from the Beehive deposit within its Orom-Cross graphite project in Uganda, reinforcing the asset’s potential to support large-scale, long-term production.

Two recently completed deep drill holes at Beehive intersected substantial mineralised zones of approximately 90 to 95 metres, with several high-grade intervals starting close to surface and remaining open at depth. Blencowe said these results build on earlier drilling success at Beehive and complement data from nearby deposits, including Iyan, Northern Syncline, and Camp Lode.

Taken together, the growing body of geological evidence points to Orom-Cross hosting a broad, continuous graphite system with the scale to underpin multi-decade mine life. The company believes this significantly enhances the project’s attractiveness to strategic partners and institutional investors, particularly as demand for secure, long-term graphite supply continues to rise.

Blencowe is currently awaiting assay results from more than 180 additional shallow drill holes, which are expected to further define the size and grade distribution of the resource. At the same time, the company is advancing funding discussions as it positions Orom-Cross as a globally competitive, low-cost graphite development.

Despite the operational progress, Blencowe continues to face financial challenges, including a lack of revenue, ongoing losses, and negative cash flow. While recent corporate activity and strategic engagement provide some longer-term optionality, these financial constraints remain a key factor influencing near-term sentiment.

More about Blencowe Resources Plc

Blencowe Resources Plc is a London-listed mining and exploration company focused on the development of the Orom-Cross graphite project in Uganda. The project is designed around large, near-surface graphite deposits, with the ambition of becoming a low-cost, long-life producer supplying high-quality graphite to global industrial and battery-related markets.

Clarkson PLC (LSE:CKN) has indicated a robust financial performance for 2025, with underlying profit before tax for the year ended 31 December 2025 now expected to be no less than £90 million, reflecting a notably stronger second half.

The trading update highlights the resilience of Clarkson’s diversified business model across shipping and offshore services. Management said the group continues to deliver consistent earnings and cash generation, supported by broad exposure to global shipping markets and disciplined capital allocation. This performance underpins Clarkson’s long-standing record of dividend growth and its ongoing investment strategy aimed at capturing opportunities across the shipping cycle.

From a market perspective, Clarkson’s financial profile remains strong, with solid revenue and profit momentum backed by a healthy balance sheet. Technical indicators point to a positive trend in the shares, although some overbought signals suggest a degree of near-term caution. Valuation metrics are viewed as reasonable, with an attractive dividend yield, while recent insider share purchases have added further confidence in the group’s outlook.

More about Clarkson PLC

Clarkson PLC is a FTSE 250-listed company and the world’s leading provider of integrated services and investment banking capabilities to the shipping and offshore sectors. Founded in 1852, the group offers shipbroking, market research, logistics support, and full investment banking services across all major shipping and offshore markets. Clarkson employs more than 2,100 people in over 60 offices worldwide and has delivered 22 consecutive years of dividend growth, supported by strong cash generation and a resilient balance sheet.

ValiRx plc (LSE:VAL) has signed a nine-month Evaluation and Material Transfer Agreement with McGill University and IRICoR to evaluate a second-generation, orally available RNA helicase inhibitor.

Under the agreement, ValiRx’s subsidiary Inaphaea Biolabs will conduct studies to confirm target engagement and potency. Inaphaea will retain ownership of all data generated during the evaluation phase, strengthening ValiRx’s control over the scientific outputs of the programme.

As part of the structure, IRICoR intends to establish a new Canadian entity, NewCo, to commercialise the evaluation results alongside relevant background intellectual property. ValiRx will hold an option to license the programme into NewCo in return for a 15% equity interest and may also provide up to £2 million in seed funding. Alternatively, should it choose not to proceed, ValiRx would be entitled to a 1.5x return on its evaluation investment.

Management said the deal is designed to promote asset-level development while limiting group-level dilution, attracting external capital, and preserving multiple strategic routes to value creation. The structure also provides flexibility to pursue opportunities across both human and veterinary health markets.

Despite the strategic rationale, ValiRx continues to face financial headwinds, including ongoing losses and reliance on external funding. Market indicators point to a generally bearish technical trend, with valuation remaining constrained by negative earnings and the absence of dividend support.

More about ValiRx plc

ValiRx plc is an AIM-listed life sciences company focused on early-stage cancer therapeutics and women’s health. Through a network of subsidiaries and collaborations with academic and research institutions, the group aims to accelerate the progression of novel drug candidates from pre-clinical research to clinic-ready assets, with a strategy centred on efficient development and eventual partnering or out-licensing.

Eden Research plc (LSE:EDEN) has achieved a key regulatory milestone after receiving approval in Chile for its fungicide Novellus+, marking the company’s first authorisation in South America.

The approval allows Novellus+ to be used on both wine and table grapes to combat grey mould and powdery mildew. The product will be marketed exclusively in Chile by Sipcam Chile SpA. Novellus+ provides residue-free disease control and can be applied up to one day before harvest, an attribute that aligns well with export-focused grape producers operating under strict residue limits.

Chile represents a strategically important market for Eden, given its position as one of the world’s leading exporters of wine and table grapes and its increasing adoption of biological and sustainable crop protection solutions. The authorisation gives Eden direct access to a sizeable and growing market while reinforcing its exposure to regions where regulators and growers are actively encouraging reduced reliance on conventional chemical fungicides.

Eden said the approval supports its longer-term growth strategy, with plans to expand the use of Novellus+ into other high-value crops in Chile over time. While the company continues to report revenue growth, its financial outlook remains constrained by ongoing profitability and cash flow pressures. Short-term technical indicators point to positive momentum, though elevated valuation risks persist due to losses and the absence of dividend income.

More about Eden Research plc

Eden Research plc is an AIM-listed agricultural technology company focused on the development of sustainable biopesticide and biocontrol products. Its portfolio is designed to deliver environmentally friendly, residue-free crop protection solutions for high-value crops, addressing increasing regulatory, consumer, and exporter demand for biological alternatives to traditional chemical pesticides.

Unite Group plc (LSE:UTG) has reaffirmed its earnings guidance for 2025 and reported stable trading conditions, while unveiling a £100 million share buyback funded by a reallocation of capital away from lower-return development opportunities.

The student accommodation specialist said demand remains resilient, with 64% of beds already reserved for the 2026/27 academic year. Despite a slower-than-usual start to the current lettings cycle—linked to universities delaying the renewal of nomination agreements—the group continues to target occupancy levels of 93–96% alongside annual rental growth of between 2% and 3%.

As part of a broader reshaping of its pipeline, Unite has cancelled its TP Paddington development and deferred a scheme in Bristol. Capital is instead being directed toward higher-conviction projects, including major university joint ventures in Newcastle and Manchester, as well as the Hawthorne House development in Stratford. The company also expects to recognise an exceptional £10 million planning-related write-off as a result of these changes.

On valuations, Unite reported modest like-for-like declines in the fourth quarter across its USAF and LSAV funds, although both vehicles delivered small capital gains over the full year. Cost discipline remains a priority, with head office restructuring under way and anticipated efficiencies expected to emerge from the planned acquisition of Empiric Student Property.

Management said these actions are designed to strengthen returns and position the business for a resumption of earnings growth from 2027. While the group benefits from strong underlying financial performance, attractive valuation metrics, and a high dividend yield, technical indicators currently point to a more cautious near-term market trend.

More about Unite Group plc

Unite Group plc, through its Unite Students brand, is the UK’s largest owner, manager, and developer of purpose-built student accommodation. The group operates a substantial portfolio across major university cities, including London, and is increasingly focused on high-tariff institutions and long-term partnerships with universities to deliver stable, sustainable returns.

1Spatial plc (LSE:SPA) has obtained an extension to the formal deadline governing a potential takeover approach from VertiGIS Ltd, providing additional time for discussions around a possible acquisition.

The UK Takeover Panel has moved the “put up or shut up” deadline to 5:00 p.m. on 30 January 2026. By that point, VertiGIS—backed by Battery Ventures—must either announce a firm intention to make an offer or confirm that it does not plan to proceed. VertiGIS is currently evaluating a possible all-cash proposal of 73 pence per share for the entire issued and to-be-issued share capital of 1Spatial.

Under takeover rules, VertiGIS retains flexibility over the structure and terms of any offer it may ultimately submit. This includes the ability, in certain circumstances, to revise pricing or adjust for any dividends declared, leaving the outcome uncertain for shareholders while negotiations continue.

Operationally, 1Spatial continues to be supported by solid financial performance and positive technical indicators. However, valuation concerns persist, with a relatively high earnings multiple and the absence of a dividend weighing on the overall investment case.

More about 1Spatial plc

1Spatial plc is a UK-listed specialist in geospatial and location data software and services. The company helps organisations manage, validate, and optimise complex spatial data, serving sectors where data accuracy is mission-critical, including government, utilities, transport, and infrastructure. The group is quoted on AIM under the ticker SPA.

Halma plc (LSE:HLMA) has agreed to acquire Italy-based Safetec Srl for €72.5 million in cash, strengthening its position in high-specification industrial safety systems and broadening its exposure to complex, high-risk project environments.

Safetec specialises in bespoke fire and gas detection solutions for large-scale industrial developments, serving sectors that include power generation, oil and gas, and pharmaceuticals. The business is expected to generate approximately €30 million in revenue in the year to 31 December 2025 and has established operations across the Middle East, Europe, and Africa.

The transaction will be completed on a cash- and debt-free basis, with Safetec continuing to operate as an independent company within Halma’s Safety sector under its existing management team. Halma said the acquisition enhances its engineering depth and provides a strong platform to support Safetec’s international expansion, while extending Halma’s reach in technically demanding industrial safety markets.

From an investment perspective, Halma continues to be supported by solid financial performance and constructive management commentary, reinforced by targeted acquisitions such as Safetec. However, its premium valuation and relatively modest dividend yield may temper near-term appeal for some investors.

More about Halma plc

Halma plc is a FTSE 100-listed global group of life-saving technology companies operating across safety, environmental, and healthcare markets. The group develops products and solutions designed to protect people and assets, address environmental and climate-related challenges, and meet growing healthcare needs. Halma employs more than 9,000 people worldwide, with operations spanning the UK, Europe, North America, and Asia-Pacific.

Hydrogen Utopia International PLC (LSE:HUI) has incorporated a wholly owned subsidiary, Hydrogen Utopia KSA, in Saudi Arabia as it steps up plans to roll out InEnTec’s waste-to-hydrogen technology across the Middle East and North Africa.

The new Saudi-based entity is intended to support project development aligned with the Kingdom’s Vision 2030 objectives, particularly around waste management, recycling, decarbonisation, and the circular economy. The move is backed by engagement and endorsements from several Saudi government-linked organisations, including Ministry of Investment of Saudi Arabia (MISA), Saudi Investment Recycling Company (SIRC), and the Research, Development and Innovation Authority (RDIA).

To support execution on the ground, the company has appointed Iman Ramani as Vice President. In this role, she will coordinate activities between London and Saudi Arabia, oversee regional stakeholder engagement, and help lead fundraising initiatives. Management said the appointment and local incorporation provide the group with a tangible operational base in a strategically important market, enhancing its credibility with regional partners and positioning it for long-term participation in Saudi Arabia’s emerging clean-energy and waste-to-value infrastructure.

Despite the strategic progress, the company’s financial profile continues to weigh on sentiment. Hydrogen Utopia remains pre-revenue, with ongoing losses, recent cash outflows, declining equity, and increasing debt levels. While technical indicators point to positive momentum in the share price, valuation remains constrained by loss-making fundamentals and the absence of dividend support.

More about Hydrogen Utopia International PLC

Hydrogen Utopia International PLC is a waste-to-energy company focused on converting non-recyclable waste streams—including mixed plastics, tyres, and hazardous materials—into hydrogen and other low-carbon fuels. Using waste as feedstock, its technology produces syngas that can be further processed into hydrogen, electricity, heat, and other gases. The group expects future revenues to be derived from energy sales and waste-processing fees, particularly in markets with strong private-sector demand and supportive public funding frameworks for alternative energy solutions.

Life Science REIT plc (LSE:LABS) has reported a sharp decline in asset values, with its property portfolio valued at £332.6 million as at 31 December 2025, representing a 7.8% reduction over the period. Unaudited EPRA net tangible assets fell by 13% to £201.8 million, equivalent to 57.7 pence per share, reflecting weaker property valuations alongside higher leverage used to fund development activity.

The downturn was largely attributed to outward yield movements across the estate, compounded by softer demand for laboratory space. Management pointed to reduced venture capital availability and lower levels of follow-on funding for life science companies as key factors weighing on occupier demand. The most pronounced impact was seen at the Cambourne Park Science and Technology Campus, where ongoing vacancies and capital expenditure requirements led valuers to reassess the site as an office or business park rather than a core life science asset.

Elsewhere in the portfolio, valuation declines were more moderate. Improving tenant demand and rising estimated rental values at Oxford Technology Park provided some support, while a lease regear at Herbrand Street in Bloomsbury was cited as a positive contributor. The company said further detail will be provided with the release of its full-year results, scheduled for April 2026.

Looking ahead, sentiment around the group remains cautious. Financial pressure, negative valuation trends, and proposed managed wind-down and asset disposal plans are weighing heavily on the outlook, overshadowing any near-term operational improvements.

More about Life Science REIT plc

Life Science REIT plc is a UK-listed real estate investment trust focused on the ownership and development of life science and technology-focused real estate. Its portfolio is concentrated in established innovation clusters, including assets within the UK’s “Golden Triangle,” and comprises science parks, laboratory-led campuses, and technology-oriented business parks.

Zoyo Limited (LSE:ZOYO) has appointed advisory firm KSA Catalyst to help advance its expansion plans across the Middle East, with an initial focus on Saudi Arabia and the broader Gulf region.

Under the engagement, KSA Catalyst will provide support on market entry strategy, regulatory engagement, partnership development, and commercial positioning. The mandate is designed to help accelerate Zoyo’s regional growth ambitions across digital assets, trading platforms, tokenisation, and related financial technology offerings, while strengthening connections with regional institutions and strategic partners.

The move reflects Zoyo’s intention to establish a stronger footprint in the Middle East as demand increases for regulated digital asset infrastructure and next-generation financial services in the region.

More about Zoyo Limited

Zoyo Limited operates within the digital assets and financial technology sector, with a focus on trading platforms, tokenisation solutions, and supporting fintech infrastructure. The company is pursuing a platform-led growth strategy aimed at addressing rising demand for advanced digital and financial asset services, with an emphasis on building long-term institutional and regional partnerships.